Whitney Smith is a partner in the firm's Corporate practice. His practice focuses
on domestic and cross-border M&A, joint venture, and private equity
transactions, including negotiated mergers, auction bid processes, distressed asset
sales, leveraged buyouts, and the acquisition and divestiture of divisions and
subsidiaries. In addition to corporate transactions, Whitney advises public
companies in connection with SEC reporting, corporate governance, and executive
compensation matters. Whitney has represented clients in a wide range of industries,
including life sciences, media services, technology, cannabis, financial
services, manufacturing, and logistics, with a particular focus on the
pharmaceutical industry.
In the pharmaceutical space, Whitney has represented clients in all types of business
development and M&A transactions, from single product Co-Development and
Commercialization Agreements to acquisitions and divestitures of manufacturing
facilities and baskets of products to full company acquisitions and FTC-mandated
product divestitures. A number of his transactions have involved acquisitions in
India.
